Experience with devices with limited availability
Mechanical circulatory support with the thoratec assist device in patients with postcardiotomy cardiogenic shock

https://doi.org/10.1016/0003-4975(95)01030-0Get rights and content

Background.

In spite of modem cardiac surgical techniques, severe cardiogenic shock not responding to pharmacologic therapy and intraaortic balloon pumping develops in about 0.2% to 1.2% of patients undergoing cardiac operations.

Methods.

From September 1987 to September 1994, 184 patients were supported with different mechanical circulatory support systems. Nine patients with postcardiotomy cardiogenic shock were supported with the Thoratec ventricular assist device. Four patients suffered early postcardiotomy cardiogenic shock, and 5 patients suffered late postcardiotomy cardiogenic shock. In 6 patients the Thoratec device was applied exclusively, in 2 patients both Bio-Medicus and Thoratec, and in 1 patient both ABIOMED and Thoratec devices were used. Duration of support ranged from 5 to 46 days with a mean duration of 15 days.

Results.

Four patients (44%) survived and were discharged. Main complications and causes of death were multiple organ failure and sepsis.

Conclusions.

The results justify the use of Thoratec assist device in patients with severe preoperative cardiogenic shock.

Cited by (30)

  • The RECOVER I: A multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support

    2013, Journal of Thoracic and Cardiovascular Surgery
    Citation Excerpt :

    No bleeding events were related to the device itself. The sepsis rate in our study was comparable to that observed in studies of patients in PCCS23 or CS requiring hemodynamic support.24 All sepsis events resolved with antibiotic treatment.

  • Circulatory assistance: Basic classification of heart assistance methods and devices

    2011, Biocybernetics and Biomedical Engineering
    Citation Excerpt :

    The main disadvantage of the rotary pumps is necessity of limiting their rotational speed because of stress and cavitation. When an extrasomatic or implanted support of the circulatory system is needed for recovery, a set of pulsatile-flow displacement assist devices usually associated with different type actuators: sac-type artificial ventricles (USA: Abiomed [5,6,8], Thoratec [17–19], Japan: Nippon-Zeon [20]), diaphragm artificial ventricles (Japan: Toyobo [21], Germany: Berlin Heart [22,23]), intra-aortic balloons [24–31] or pusher-plate type units [4,32] are available as a bridge to transplant or total artificial heart. Mechanical heart-assistance methods and devices, regarding the place of its connection to the circulatory system, can be divided into two groups:

  • Biventricular mechanical replacement

    2004, Surgical Clinics of North America
  • Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock

    2002, Annals of Thoracic Surgery
    Citation Excerpt :

    Its effect is limited or not possible in patients with profound heart failure, tachyarrhythmia, small body weight, or right heart failure. Successful use of HeartMate VAD [4] and Thoratec VAD [5] for PCS has been reported. However, due to technical complexity, these VADs are not suitable for critical patients in emergencies.

View all citing articles on Scopus
View full text